
Keywords: BAPC; bioreductively activatable prodrug conjugate; CA1; combretastatin A-1; CA4; combretastatin A-4; Et3N; triethylamine; HPLC; high performance liquid chromatography; HRMS; high resolution mass spectrometry; MeOH; methanol; NaBH4; sodium borohydride; TL